Literature DB >> 12050630

Therapeutic antibodies: magic bullets hit the target.

Trisha Gura.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12050630     DOI： 10.1038/417584a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  24 in total

1.  Induction of long-term protective antiviral endogenous immune response by short neutralizing monoclonal antibody treatment.

Authors:  Laurent Gros; Hanna Dreja; Anne Laure Fiser; Marc Plays; Mireia Pelegrin; Marc Piechaczyk
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

2.  Affinity maturation of antibodies assisted by in silico modeling.

Authors:  Rodrigo Barderas; Johan Desmet; Peter Timmerman; Rob Meloen; J Ignacio Casal
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-23       Impact factor: 11.205

Review 3.  The development of therapeutic monoclonal antibodies: overview of the nonclinical safety assessment.

Authors:  Janice A Lansita; Barbara Mounho-Zamora
Journal:  Curr Pain Headache Rep       Date:  2015

4.  Cloned transgenic farm animals produce a bispecific antibody for T cell-mediated tumor cell killing.

Authors:  Ludger Grosse-Hovest; Sigrid Müller; Rosa Minoia; Eckhard Wolf; Valeri Zakhartchenko; Hendrik Wenigerkind; Caroline Lassnig; Urban Besenfelder; Mathias Müller; Simon D Lytton; Gundram Jung; Gottfried Brem
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-22       Impact factor: 11.205

5.  Effective therapy for a murine model of human anaplastic large-cell lymphoma with the anti-CD30 monoclonal antibody, HeFi-1, does not require activating Fc receptors.

Authors:  Meili Zhang; Zhengsheng Yao; Zhuo Zhang; Kayhan Garmestani; Carolyn K Goldman; Jeffrey V Ravetch; John Janik; Martin W Brechbiel; Thomas A Waldmann
Journal:  Blood       Date:  2006-03-21       Impact factor: 22.113

6.  Antibodies on demand: a fast method for the production of human scFvs with minimal amounts of antigen.

Authors:  Ingrid Babel; Rodrigo Barderas; Alberto Peláez-García; J Ignacio Casal
Journal:  BMC Biotechnol       Date:  2011-06-02       Impact factor: 2.563

7.  An efficient vector system to modify cells genetically.

Authors:  Huamin Han; Qingjun Liu; Wen He; Kristy Ong; Xiaoli Liu; Bin Gao
Journal:  PLoS One       Date:  2011-11-11       Impact factor: 3.240

Review 8.  scFv antibody: principles and clinical application.

Authors:  Zuhaida Asra Ahmad; Swee Keong Yeap; Abdul Manaf Ali; Wan Yong Ho; Noorjahan Banu Mohamed Alitheen; Muhajir Hamid
Journal:  Clin Dev Immunol       Date:  2012-03-15

Review 9.  Single domain antibodies: promising experimental and therapeutic tools in infection and immunity.

Authors:  Janusz Wesolowski; Vanina Alzogaray; Jan Reyelt; Mandy Unger; Karla Juarez; Mariela Urrutia; Ana Cauerhff; Welbeck Danquah; Björn Rissiek; Felix Scheuplein; Nicole Schwarz; Sahil Adriouch; Olivier Boyer; Michel Seman; Alexei Licea; David V Serreze; Fernando A Goldbaum; Friedrich Haag; Friedrich Koch-Nolte
Journal:  Med Microbiol Immunol       Date:  2009-06-16       Impact factor: 3.402

10.  T-cell receptor specificity maintained by altered thermodynamics.

Authors:  Florian Madura; Pierre J Rizkallah; Kim M Miles; Christopher J Holland; Anna M Bulek; Anna Fuller; Andrea J A Schauenburg; John J Miles; Nathaniel Liddy; Malkit Sami; Yi Li; Moushumi Hossain; Brian M Baker; Bent K Jakobsen; Andrew K Sewell; David K Cole
Journal:  J Biol Chem       Date:  2013-05-22       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.